Lung Cancer Screening Registry and Quality Improvement Act of 2021.

To provide funds to the Centers for Medicare & Medicaid Services to provide grants to entities to establish lung cancer screening registries approved by the Centers for Medicare & Medicaid Services for submission of certain data required for reimbursement under the Medicare program for certain screening services, and for other purposes. 1. Short title This Act may be cited as the Lung Cancer Screening Registry and Quality Improvement Act of 2021. 2. Grants to establish lung cancer screening registries approved by the Centers for Medicare & Medicaid Services for submission of certain data required for reimbursement under the Medicare program for certain screening services (a) Grants There is appropriated to the Centers for Medicare & Medicaid Services, out of any moneys in the Treasury not otherwise appropriated, $2,000,000 for each of fiscal years 2022 through 2026 to make grants to entities to establish and carry out registries that are approved by the Centers for Medicare & Medicaid Services as meeting the requirements described in the Final National Coverage Determination on Screening for Lung Cancer with Low Dose Computed Tomography published on February 5, 2015. (b) Limitation As a condition of receiving a grant pursuant to subsection (a), with respect to a registry described in such subsection, an entity may not charge any fee for access to such registry. 3. Encouraging data interoperability among lung cancer screening registries The Secretary of Health and Human Services shall take such actions as may be necessary to ensure data interoperability between all registries described in section 1(a) (including such registries established using funds provided under such section, interoperability between all CMS-approved lung cancer screening registries), including by— (1) requiring interoperability as a condition of receiving any Federal funding for such a registry; and (2) revoking any such funding for such a registry if the registry is not interoperable with other such registries. 4. Grants for the development of lung cancer screening, detection, and prevention quality measures (a) In general Subject to subsection (c), the Secretary of Health and Human Services shall award competitive grants to organizations with quality measure development expertise to develop, using data contained in registries described in section 1(a) (including such a registry established using funds provided under such section), quality and efficiency measures described in subsection (b) for review and potential endorsement by a consensus-based entity with a contract in effect under section 1890 of the Social Security Act ( 42 U.S.C. 1395aaa (b) Quality and efficiency measures described For purposes of subsection (a), quality and efficiency measures described in this subsection are quality and efficiency measures to improve health care efficiency and outcomes with respect to lung cancer screening practices, early detection of lung cancer, and lung cancer prevention. (c) Authorization of appropriations There is authorized to be appropriated to carry out subsection (a) $1,000,000 for each of fiscal years 2022 through 2026.

Summary: Lung Cancer Screening Registry and Quality Improvement Act of 2021 This bill establishes several grant programs and requirements for registries that collect data from lung cancer screenings with low-dose computed tomography (LDCT) under Medicare. (Currently, for purposes of Medicare coverage, radiology imaging facilities that furnish such LDCT screenings must report certain data to approved registries.) Specifically, the bill provides funds for FY2022-FY2026 for grants to help entities establish free registries, and requires registries to be interoperable in order to receive federal funds. The bill also provides grants to support the development of related quality measures for lung cancer screenings.